NOVAN Nitric Oxide-Based Medicine
We use our proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs.
Press Releases
-
October 21, 2020
Novan to Present at the Virtual Investor KOL Roundtable
-
October 14, 2020
Novan’s NITRICIL™ Technology Shows In Vitro Antiviral Effect Against SARS-CoV-2 in Human Airway Infection Model
-
September 24, 2020
Novan Strengthens Financial Leadership with Appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors
